Scrutinizing enrollment in ALS clinical trials: Room for improvement?

Amyotrophic Lateral Sclerosis

Volumn 9, Issue 5, 2008, Pages 257-265

  Bedlack, Richard S ^a   Pastula, Daniel ^a   Welsh, Emily ^b   Pulley, Darlene ^b   Cudkowicz, Merit E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ALS; Clinical trials; Enrollment

Indexed keywords

4 PHENYLBUTYRIC ACID; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ARIMOCLOMOL; BETA1A INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; CELECOXIB; CREATINE; DEXTROMETHORPHAN; ETIDRONIC ACID; ETIRACETAM; GABAPENTIN; GLATIRAMER; GLUTATHIONE; MINOCYCLINE; NEUROTROPHIC FACTOR; PENTOXIFYLLINE; PLACEBO; RILUZOLE; SOMATOMEDIN C; TCH 346; TOPIRAMATE; UNCLASSIFIED DRUG; VERAPAMIL; XALIPRODEN;

ADMINISTRATIVE PERSONNEL; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EXERCISE; HEALTH CARE FACILITY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; NORTH AMERICA; ONLINE SYSTEM; PATIENT ATTITUDE; PATIENT PARTICIPATION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RESEARCH SUBJECT;

AMYOTROPHIC LATERAL SCLEROSIS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; HUMANS; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; TREATMENT OUTCOME;

EID: 52749092495     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802195913     Document Type: Article

References (27)

1. Brooks, BR. (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci., 124, pp. 96-107.
2. Brooks, BR, Miller, RG, Swash, M., Munsat, TL and World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1, pp. 293-299.
3. Cudkowicz, M. and Shefner, J. (2004) North East ALS Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord., 5, pp. 125-127.
4. Miller, RG, Moore, DH and Jackson, CE. (2004) Western ALS Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord., 5, pp. 121-124.
5. Meininger, V. (2004) European ALS Consortium. Amyotroph Lateral Scler Other Motor Neuron Disord., 5, pp. 133-134.
6. Cedarbaum, JM, Stambler, N., Malta, E., Fuller, C., Hilt, D. Thurmond, B. et al. (1999) The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci., 169, pp. 13-21.
7. Simmons, Z., Felgoise, SH, Bremer, BA, Walsh, SM, Hufford, DJ Bromberg, MB et al. (2006) The ALSSQOL: Balancing physical and non-physical factors in assessing quality of life in ALS. Neurology, 67, pp. 1659-1664.
8. Bowser, R., Cudkowicz, M. and Kaddurah-Daouk, R. (2006) Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn., 6, pp. 387-398.
9. Cheung, Y., Gordon, P. and Levin, B. (2006) Selecting promising ALS therapies in clinical trials. Neurology., 67, pp. 1748-1751.
10. Bedlack, RS, Traynor, BJ and Cudkowicz, ME. (2007) Emerging disease-modifying therapies for the treatment of motor neuron disease/ amyotrophic lateral sclerosis. Expert Opin Emerging Drugs., 12, pp. 229-252.
11. Traynor, BJ, Alexander, M., Corr, B., Frost, E. and Hardiman, O. (2003) Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: A population based study, 1996-2000. J Neurol Neurosurg Psychiatry, 74, pp. 1258-1261.
12. Davis, S., Wright, PW, Schulman, SF, Hill, LD, Pinkham, RD Johnson, LP et al. (1985) Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with non-participants. Cancer., 56, pp. 1710-1718.
13. Reiser, J. and Warner, JO. (1985) The value of participating in an asthma trial. Lancet. Jan; 1, 26:18422, pp. 206-207.
14. Croteau, H., Brisson, N., Lemaire, J. and Latreille, J. (2005) The benefit of participating to clinical research. Breast Cancer Research and Treatment., 91, pp. 279-281.
15. Cudkowicz, ME, Shefner, JM, Schoenfeld, DA, Brown, RH, Johnson, H. Qureshi, M. et al. (2003) A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology., 61, pp. 456-464.
16. Gordon, PH, Moore, DH, Miller, RG, Florence, JM, Verheijde, JL Doorish, C. et al. Lancet Neurology
17. (1991) American Medical Association Council on Scientific Affairs: visibility and cancer clinical research, patient accrual, coverage, and reimbursement. J Natl Cancer Inst, 83, pp. 254-259.
18. The Cancer Letter (2000) To improve clinical trials participation, groups plan an awareness campaign. The Cancer Letter, 26, pp. 1-3.
19. Cancer Leadership Council. Improving Communication and Public Awareness
20. Ellis, P. (1999) Attitudes toward participation in randomized clinical trials in oncology: A review of the literature. Annals of Oncology., 11, pp. 939-945.
21. Comis, RL, Miller, JD, Aldigé, CR, Krebs, L. and Stoval, E. A quantitative survey of public attitudes towards cancer clinical trials.
22. Lara Jr, PN, Higdon, R., Lim, N., Kwan, K., Tanaka, M. Lau, DH et al. (2001) Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol., 19, pp. 1728-1733.
23. Grossman, SA, Piantadosi, S. and Covahey, C. (1994) Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?. J Clin Oncol., 12, pp. 2211-2215.
24. Daugherty, CK, Lyman, K., Mick, R., Siegler, M. Ratain, MJ et al. (1996) Differences in perceptions of goals, expectations, and level of informed consent in phase I clinical trials. Proc Am Soc Clin Oncol., 15, p. 352.
25. Daugherty, CK, Kialbasa, TA, Siegler, M. Ratain, MJ et al. (1997) Informed consent in clinical research: A study of cancer patient understanding of consent forms and alternatives of care in phase I clinical trials. Proc Am Soc Clin Oncol., 16, p. 188.
26. Simes, RJ, Tattersall, MH, Coates, AS, Raghavan, D., Solomon, HJ and Smartt, H. (1986) Randomized comparison of procedures for obtaining informed consent in clinical trials of cancer. BMH, 293, pp. 1065-1068.
27. Aaronson, NK, Visser-Pol, E., Leenhouts, GH, Muller, MJ, van der Schot, AC van Dam, FS et al. (1996) Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol, 14, pp. 984-996.